Commission Regulation (EU) No 500/2013 of 30 May 2013 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetamiprid, Adoxophyes orana granulovirus strain BV-0001, azoxystrobin, clothianidin, fenpyrazamine, heptamaloxyloglucan, metrafenone, Paecilomyces lilacinus strain 251, propiconazole, quizalofop-P, spiromesifen, tebuconazole, thiamethoxam and zucchini yellow mosaik virus - weak strain in or on certain products
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XII Foodstuffs
Joint committee decision (JCD)
221/2013 In force in the EEA
Yes Legal documents
Commission Regulation (EU) No 500/2013 of 30 May 2013 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetamiprid, Adoxophyes orana granulovirus strain BV-0001, azoxystrobin, clothianidin, fenpyrazamine, heptamaloxyloglucan, metrafenone, Paecilomyces lilacinus strain 251, propiconazole, quizalofop-P, spiromesifen, tebuconazole, thiamethoxam and zucchini yellow mosaik virus - weak strain in or on certain products
Reglugerð framkvæmdastjórnarinnar (ESB) nr. 500/2013 frá 30. maí 2013 um breytingu á II., III. og IV. viðauka við reglugerð Evrópuþingsins og ráðsins (EB) nr. 396/2005 að því er varðar hámarksgildi leifa fyrir asetamípríð, stofn BV-0001 af Adoxophyes orana granulovirus, asoxýstróbín, klóþíanidín, fenpýrasamín, heptamaloxýlóglúkan, metrafenón, stofn 251 af Paecilomyces lilacinus, própíkónasól, kvisalófóp-P, spírómesífen, tebúkónasól, þíametoxam og veikan stofn af kúrbítsgulmósaíkveiru í eða á tilteknum afurðum
Verordnung (EU) Nr. 500/2013 der Kommission vom 30. Mai 2013 zur Änderung der Anhänge II, III und IV der Verordnung (EG) Nr. 396/2005 des Europäischen Parlaments und des Rates bezüglich der Rückstandshöchstgehalte für Acetamiprid, Adoxophyes orana granulovirus Stamm BV-0001, Azoxystrobin, Clothianidin, Fenpyrazamin, Heptamaloxyloglucan, Metrafenon, Paecilomyces lilacinus Stamm 251, Propiconazol, Quizalofop-P, Spiromesifen, Tebuconazol, Thiamethoxam und Zucchinigelbmosaikvirus - abgeschwächter Stamm in oder auf bestimmten Erzeugnissen
Kommisjonsforordning (EU) nr. 500/2013 av 30. mai 2013 om endring av vedlegg II, III og IV til europaparlaments- og rådsforordning (EF) nr. 396/2005 med hensyn til grense¬verdier for rester av acetamiprid, Adoxophyes orana granulovirus stamme BV-0001, azoksystrobin, klotianidin, fenpyrazamin, heptamaloksyloglukan, metrafenon, Paecilomyces lilacinus stamme 251, propikonazol, kizalofop-P, spiromesifen, tebukonazol, tiametoksam og zucchinigulmosaikkvirus – svak stamme i eller på visse produkter
History
14.12.2013
Adopted JCD confirmed entry into force date
14.12.2013
Compliance date in the EEA
13.12.2013
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
16.10.2013
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
30.05.2013
Adoption date in the EU
05.06.2013
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.